[MO4-3] Adverse events of sequential tyrosine kinase inhibitor following immune checkpoint inhibitor in advanced NSCLC patients
Abstract password authentication.
The password can be found on page 27 of the program book.
Mini-Oral Session
Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 6 (Room D, 1F, Kyoto International Conference Center)
Chair:Hiroyasu Kaneda(Department of Clinical Oncology, Osaka City University),Ikuo Sekine(Department of Medical Oncology, University of Tsukuba Faculty of Medicine)
Abstract password authentication.
The password can be found on page 27 of the program book.